These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 12198218

  • 1. CAHP-210 dialyzer influence on intra-dialytic vancomycin removal.
    Lucksiri A, Scott MK, Mueller BA, Hamburger RJ, Sowinski KM.
    Nephrol Dial Transplant; 2002 Sep; 17(9):1649-54. PubMed ID: 12198218
    [Abstract] [Full Text] [Related]

  • 2. Effects of dialysis membrane on intradialytic vancomycin administration.
    Scott MK, Macias WL, Kraus MA, Clark WR, Carfagna MA, Mueller BA.
    Pharmacotherapy; 1997 Sep; 17(2):256-62. PubMed ID: 9085316
    [Abstract] [Full Text] [Related]

  • 3. A Pharmacokinetic Study Comparing the Clearance of Vancomycin during Haemodialysis Using Medium Cut-Off Membrane (Theranova) and High-Flux Membranes (Revaclear).
    Allawati H, Dallas L, Nair S, Palmer J, Thaikandy S, Hutchison C.
    Toxins (Basel); 2020 May 12; 12(5):. PubMed ID: 32408589
    [Abstract] [Full Text] [Related]

  • 4. Comparison of 3 vancomycin dosage regimens during hemodialysis with cellulose triacetate dialyzers: post-dialysis versus intradialytic administration.
    Mason NA, Neudeck BL, Welage LS, Patel JA, Swartz RD.
    Clin Nephrol; 2003 Aug 12; 60(2):96-104. PubMed ID: 12940611
    [Abstract] [Full Text] [Related]

  • 5. Removal of vancomycin administered during dialysis by a high-flux dialyzer.
    Nyman HA, Agarwal A, Senekjian HO, Leypoldt JK, Cheung AK.
    Hemodial Int; 2018 Jul 12; 22(3):383-387. PubMed ID: 29380499
    [Abstract] [Full Text] [Related]

  • 6. Influence of cellulose triacetate hemodialyzers on vancomycin pharmacokinetics.
    Welage LS, Mason NA, Hoffman EJ, Odeh RM, Dombrouski J, Patel JA, Swartz RD.
    J Am Soc Nephrol; 1995 Oct 12; 6(4):1284-90. PubMed ID: 8589298
    [Abstract] [Full Text] [Related]

  • 7. Vancomycin mass transfer characteristics of high-flux cellulosic dialysers.
    Scott MK, Mueller BA, Clark WR.
    Nephrol Dial Transplant; 1997 Dec 12; 12(12):2647-53. PubMed ID: 9430866
    [Abstract] [Full Text] [Related]

  • 8. Cefazolin dialytic clearance by high-efficiency and high-flux hemodialyzers.
    Sowinski KM, Mueller BA, Grabe DW, Manley HJ, Frye RF, Bailie GR, Marx MA.
    Am J Kidney Dis; 2001 Apr 12; 37(4):766-76. PubMed ID: 11273877
    [Abstract] [Full Text] [Related]

  • 9. Pharmacokinetics of vancomycin in patients undergoing haemodialysis and haemofiltration.
    De Bock V, Verbeelen D, Maes V, Sennesael J.
    Nephrol Dial Transplant; 1989 Apr 12; 4(7):635-9. PubMed ID: 2510061
    [Abstract] [Full Text] [Related]

  • 10. Pharmacokinetics of vancomycin when administered during high flux hemodialysis.
    Foote EF, Dreitlein WB, Steward CA, Kapoian T, Walker JA, Sherman RA.
    Clin Nephrol; 1998 Jul 12; 50(1):51-5. PubMed ID: 9710347
    [Abstract] [Full Text] [Related]

  • 11. Adequacy of a vancomycin dosing regimen in patients receiving high-flux hemodialysis.
    Ariano RE, Fine A, Sitar DS, Rexrode S, Zelenitsky SA.
    Am J Kidney Dis; 2005 Oct 12; 46(4):681-7. PubMed ID: 16183423
    [Abstract] [Full Text] [Related]

  • 12. Vancomycin during the Last Hour of the Hemodialysis Session: A Pharmacokinetic Analysis.
    Ghouti-Terki L, Chasseuil E, Rabot N, Paintaud G, François M, Birmelé B, Darrouzain F, Büchler M, Halimi JM, Ternant D.
    Nephron; 2017 Oct 12; 135(4):261-267. PubMed ID: 28152540
    [Abstract] [Full Text] [Related]

  • 13. Falsely elevated serum vancomycin concentrations in hemodialysis patients.
    Follin SL, Mueller BA, Scott MK, Carfagna MA, Kraus MA.
    Am J Kidney Dis; 1996 Jan 12; 27(1):67-74. PubMed ID: 8546140
    [Abstract] [Full Text] [Related]

  • 14. Dosage recommendation of vancomycin during haemodialysis with highly permeable membranes.
    Zoer J, Schrander-van der Meer AM, van Dorp WT.
    Pharm World Sci; 1997 Aug 12; 19(4):191-6. PubMed ID: 9297732
    [Abstract] [Full Text] [Related]

  • 15. Vancomycin serum concentrations in patients with renal dysfunction: a comparison of fluorescence polarization immunoassay and the enzyme-multiplied immunoassay technique.
    Peckman HJ, Dupuis RE, Sawyer WT, Brouwer KL, Cross RE.
    Ther Drug Monit; 1996 Dec 12; 18(6):647-53. PubMed ID: 8946660
    [Abstract] [Full Text] [Related]

  • 16. [Measurements of vancomycin concentrations in the blood - a method of personalization the antibiotic therapy in patients with chronic kidney disease].
    Pondel J, Krajewski P, Królikowska N, Tobiasz A, Augustyniak-Bartosik H, Hurkacz M.
    Pol Merkur Lekarski; 2017 Apr 21; 42(250):145-150. PubMed ID: 28530212
    [Abstract] [Full Text] [Related]

  • 17. Clearance of vancomycin during high-efficiency hemodialysis.
    Klansuwan N, Ratanajamit C, Kasiwong S, Wangsiripaisan A.
    J Med Assoc Thai; 2006 Jul 21; 89(7):986-91. PubMed ID: 16881431
    [Abstract] [Full Text] [Related]

  • 18. Effects of slowly performed daytime hemodialysis (slow HD) on the pharmacokinetics of vancomycin in hemodynamically unstable patients with renal failure.
    Kihara M, Ikeda Y, Fujita H, Tamura K, Yabana M, Takagi N, Umemura S, Ishii M.
    Blood Purif; 1996 Jul 21; 14(1):20-5. PubMed ID: 8718561
    [Abstract] [Full Text] [Related]

  • 19. An open-label, non-randomised, phase 1, single-dose study to assess the pharmacokinetics of ceftaroline in patients with end-stage renal disease requiring intermittent haemodialysis.
    Sunzel M, Learoyd M, Li J, Li Y, Ngo N, Edeki T.
    Int J Antimicrob Agents; 2015 Dec 21; 46(6):682-8. PubMed ID: 26545441
    [Abstract] [Full Text] [Related]

  • 20. Urea kinetics and dialysis treatment time predict vancomycin elimination during high-flux hemodialysis.
    Schaedeli F, Uehlinger DE.
    Clin Pharmacol Ther; 1998 Jan 21; 63(1):26-38. PubMed ID: 9465839
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.